Matulonis, Ursula A <br/><br/>
Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Jul 2012 
 - 41-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2012.04.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bevacizumab<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Pilot Projects<br/>Prospective Studies<br/>Treatment Outcome